Status:

COMPLETED

Handwriting as an Objective Tool to Support the Identification of People With Alzheimer's Disease

Lead Sponsor:

University of Évora

Collaborating Sponsors:

NOVA Medical School

Faculdade de Motricidade Humana

Conditions:

Dementia

Eligibility:

All Genders

50+ years

Brief Summary

Alzheimer's disease (AD) is the most common of dementia, and has associated cognitive and motor disorders, with consequences on daily activities, including handwriting. Handwriting has been used to s...

Detailed Description

The minimum sample size for this pilot study is 75 participants, which is the minimum sample size calculated by G\*power (90% power, significance level 0.05) to perform the planned between-group compa...

Eligibility Criteria

Inclusion

  • Dementia group
  • Inclusion criteria:
  • Over 50 years of age
  • The inclusion criteria for the dementia group are as follows: patients diagnosed with dementia according to the DSM-5 criteria and cognitive impairment proven in the neuropsychological assessment
  • Portuguese native language
  • Exclusion criteria:
  • \- Previous neurological history (e.g. stroke, traumatic brain injury, multiple sclerosis, among others), psychiatric history or other incapacitating illnesses that could interfere with the collection of writing data. (NOTE that neurological disease is accepted in the dementia group, but co-morbidity of previous and actual neurological diseases will be excluded) Cognitively normal group
  • Inclusion criteria:
  • Over 50 years of age
  • At least three years of schooling
  • Exclusion criteria:
  • \- Presence of neurological history (e.g., stroke, traumatic brain injury, multiple sclerosis, among others), psychiatric history, or other incapacitating illnesses that could interfere with the collection of writing data.

Exclusion

    Key Trial Info

    Start Date :

    December 2 2023

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    July 30 2024

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT06483438

    Start Date

    December 2 2023

    End Date

    July 30 2024

    Last Update

    August 9 2024

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Espírito Santo Hospital of Évora

    Evora, Portugal, 7000

    2

    Casa dos Avós Residence

    Ponte de Sôr, Portugal, 7400

    3

    Costa Azul Residence

    Sesimbra, Portugal, 2970

    Handwriting as an Objective Tool to Support the Identification of People With Alzheimer's Disease | DecenTrialz